Yunnan Baiyao Group Co.,Ltd (SHE:000538)
China · Delayed Price · Currency is CNY | Market Cap | 96.87B -3.7% |
| Revenue (ttm) | 41.19B +2.9% |
| Net Income | 5.15B +8.5% |
| EPS | 2.89 +8.6% |
| Shares Out | 1.78B |
| PE Ratio | 18.79 |
| Forward PE | 17.07 |
| Dividend | 2.60 (4.78%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 10,140,844 |
| Average Volume | 7,319,397 |
| Open | 54.45 |
| Previous Close | 54.29 |
| Day's Range | 54.20 - 54.85 |
| 52-Week Range | 53.90 - 60.69 |
| Beta | 0.27 |
| RSI | 45.83 |
| Earnings Date | Apr 1, 2026 |
About SHE:000538
Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmace... [Read more]
Financial Performance
In 2025, SHE:000538's revenue was 41.19 billion, an increase of 2.88% compared to the previous year's 40.03 billion. Earnings were 5.15 billion, an increase of 8.51%.
Financial StatementsNews
Fast-rising Toothpaste Newcomer Brushes Up For Hong Kong IPO
Xiaokuo Technology, the name behind the Canban brand, could be the first member of its class to list in Hong Kong, growing at lightning speed through savvy use of online KOLs image credit: Bamboo Work...